You have 9 free searches left this month | for more free features.

Condition

Carcinoma, Non-Small-Cell Lung (1)

Neoplasms, Ovarian (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Bristol-Myers Squibb (2)

Collaborator

Eisai Inc. (1)

Intervention

morab-202 (2)

paclitaxel (1)

pegylated liposomal doxorubicin (pld) (1)

topotecan (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

morab-202

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC Trial in Worldwide (MORAb-202)

Recruiting

Carcinoma, Non-Small-Cell Lung

MORAb-202

Lone Tree, Colorado
+21 more

Jan 17, 2023

Tumors, Ovarian Trial in Worldwide (MORAb-202, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD))

Not yet recruiting

Neoplasms, Ovarian

MORAb-202
+3 more

Orange, California
+38 more

Nov 4, 2022